1,283 more words
Many of our Clients have been saying how hypercompetitive their markets have become. This is especially true in Diabetes with the newer classes as well as in Oncology, Cardiovascular and other therapy areas.
Tags » Pharmaceutical Marketing
When a pharmaceutical company in China realized it needed outside help to identify and close the gaps in its R&D portfolio, its leaders turned to Ozmosi for a complete, bottom-up portfolio management solution. 285 more words
The Asia-Pacific R&D unit of a large, multinational pharmaceutical company needed a pipeline prioritization approach to guide regional investment and development efforts to maximize continued growth. 270 more words